말초동맥질환 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "말초동맥질환" in Korean language version.

refsWebsite
Global rank Korean rank
2nd place
3rd place
4th place
4th place
1st place
1st place
low place
low place
8,639th place
1,318th place
6,464th place
3,647th place

doi.org

dx.doi.org

  • Violi, F; Basili, S; Berger, JS; Hiatt, WR (2012). “Antiplatelet therapy in peripheral artery disease.”. 《Handbook of experimental pharmacology》 (210): 547–63. doi:10.1007/978-3-642-29423-5_22. PMID 22918746. 
  • Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ (Oct 2012). “Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men”. 《JAMA》 308 (16): 1660–7. doi:10.1001/jama.2012.13415. PMID 23093164. 
  • Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA (2001). “Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study”. 《American Journal of Epidemiology》 153 (7): 666–672. doi:10.1093/aje/153.7.666. PMID 11282794. 
  • Allison MA, Denenberg JO, Criqui MH (2011). “Family History of Peripheral Artery Disease Is Associated With Prevalence and Severity of Peripheral Artery Disease”. 《Journal of the American College of Cardiology》 58 (13): 1386–92. doi:10.1016/j.jacc.2011.06.023. PMID 21920269. 
  • Valentine RJ, Guerra R, Stephan P, Scoggins E, Clagett GP, Cohen J (2004). “Family history is a major determinant of subclinical peripheral arterial disease in young adults”. 《Journal of vascular surgery》 39 (2): 351–356. doi:10.1016/j.jvs.2003.07.011. 
  • Ridker PM, Stampfer MJ, Rifai N (2001). “Novel risk factors for systemic atherosclerosis”. 《JAMA: the journal of the American Medical Association》 285 (19): 2481–2485. doi:10.1001/jama.285.19.2481. 
  • TASC II Guidelines
    * Norgren L, Hiatt WR, Dormandy JA; Hiatt; 외. (2007). “Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)”. 《Eur J Vasc Endovasc Surg.》 33 (Suppl 1): S1–75. doi:10.1016/j.ejvs.2006.09.024. PMID 17140820. 
    * Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group, 외. (2007). “Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)”. 《J Vasc Surg.》 45 (Suppl S): S5–67. doi:10.1016/j.jvs.2006.12.037. PMID 17223489. 
    * Norgren L, Hiatt WR, Dormandy JA (2007). “Inter-Society Consensus for the Management of Peripheral Arterial Disease”. 《Int Angiol.》 26 (2): 81–157. PMID 17489079. 
  • Burns P, Gough S, Bradbury AW; Gough; Bradbury (March 2003). “Management of peripheral arterial disease in primary care”. 《BMJ》 326 (7389): 584–8. doi:10.1136/bmj.326.7389.584. PMC 1125476. PMID 12637405. 
  • Robless P, Mikhailidis DP, Stansby GP; Mikhailidis; Stansby (2008). Robless, Peter, 편집. “Cilostazol for peripheral arterial disease”. 《Cochrane Database Syst Rev》 (1): CD003748. doi:10.1002/14651858.CD003748.pub3. PMID 18254032. 
  • Salhiyyah, Kareem; Senanayake, Eshan; Abdel-Hadi, Mohammed; Booth, Andrew; Michaels, Jonathan A (2012). Salhiyyah, Kareem, 편집. “Pentoxifylline for intermittent claudication”. 《Cochrane Database of Systematic Reviews》 (Systematic Review) 1: CD005262. doi:10.1002/14651858.CD005262.pub2. PMID 22258961. 

heart.org

heart.org》

merck.com

nih.gov

ncbi.nlm.nih.gov

  • Violi, F; Basili, S; Berger, JS; Hiatt, WR (2012). “Antiplatelet therapy in peripheral artery disease.”. 《Handbook of experimental pharmacology》 (210): 547–63. doi:10.1007/978-3-642-29423-5_22. PMID 22918746. 
  • Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ (Oct 2012). “Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men”. 《JAMA》 308 (16): 1660–7. doi:10.1001/jama.2012.13415. PMID 23093164. 
  • Hooi JD, Kester AD, Stoffers HE, Overdijk MM, van Ree JW, Knottnerus JA (2001). “Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study”. 《American Journal of Epidemiology》 153 (7): 666–672. doi:10.1093/aje/153.7.666. PMID 11282794. 
  • Allison MA, Denenberg JO, Criqui MH (2011). “Family History of Peripheral Artery Disease Is Associated With Prevalence and Severity of Peripheral Artery Disease”. 《Journal of the American College of Cardiology》 58 (13): 1386–92. doi:10.1016/j.jacc.2011.06.023. PMID 21920269. 
  • TASC II Guidelines
    * Norgren L, Hiatt WR, Dormandy JA; Hiatt; 외. (2007). “Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)”. 《Eur J Vasc Endovasc Surg.》 33 (Suppl 1): S1–75. doi:10.1016/j.ejvs.2006.09.024. PMID 17140820. 
    * Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group, 외. (2007). “Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)”. 《J Vasc Surg.》 45 (Suppl S): S5–67. doi:10.1016/j.jvs.2006.12.037. PMID 17223489. 
    * Norgren L, Hiatt WR, Dormandy JA (2007). “Inter-Society Consensus for the Management of Peripheral Arterial Disease”. 《Int Angiol.》 26 (2): 81–157. PMID 17489079. 
  • Fontaine R, Kim M, Kieny R; Kim; Kieny (1954). “Die chirugische Behandlung der peripheren Durchblutungsstörungen. (Surgical treatment of peripheral circulation disorders)”. 《Helvetica Chirurgica Acta》 (독일어) 21 (5/6): 499–533. PMID 14366554. 
  • Burns P, Gough S, Bradbury AW; Gough; Bradbury (March 2003). “Management of peripheral arterial disease in primary care”. 《BMJ》 326 (7389): 584–8. doi:10.1136/bmj.326.7389.584. PMC 1125476. PMID 12637405. 
  • Robless P, Mikhailidis DP, Stansby GP; Mikhailidis; Stansby (2008). Robless, Peter, 편집. “Cilostazol for peripheral arterial disease”. 《Cochrane Database Syst Rev》 (1): CD003748. doi:10.1002/14651858.CD003748.pub3. PMID 18254032. 
  • Salhiyyah, Kareem; Senanayake, Eshan; Abdel-Hadi, Mohammed; Booth, Andrew; Michaels, Jonathan A (2012). Salhiyyah, Kareem, 편집. “Pentoxifylline for intermittent claudication”. 《Cochrane Database of Systematic Reviews》 (Systematic Review) 1: CD005262. doi:10.1002/14651858.CD005262.pub2. PMID 22258961. 

nhlbi.nih.gov

web.archive.org